Literature DB >> 22759982

Are patients whose study partners are spouses more likely to be eligible for Alzheimer's disease clinical trials?

Joshua D Grill1, Sarah Monsell, Jason Karlawish.   

Abstract

BACKGROUND/AIMS: Alzheimer's disease (AD) clinical trials enroll two participants: a patient and a study partner. The primary caregiver most often fills the role of study partner and most trial study partners are spousal caregivers.
METHODS: AD trial inclusion criteria were applied to baseline data from 5,674 probable AD dementia research participants in the National Alzheimer's Coordinating Center Uniform Data Set. Eligibility was compared among patients with spousal, adult child, and other types of study partners.
RESULTS: Patients with spousal study partners were more frequently eligible than patients with adult child study partners. Compared to patients with spousal study partners, patients with adult child study partners were more frequently ineligible because of age, residence in skilled nursing facility, low scores on the Mini-Mental State Examination, highscores on the Hachinski Ischemia Scale, and failure to fulfill a minimum number of weekly visits with the study partner.
CONCLUSIONS: In this sample, patients with adult child study partners were less likely to qualify for AD clinical trials than were patients with spousal study partners. This may contribute to the lower representation of patients with adult child caregivers in these studies.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 22759982      PMCID: PMC3477789          DOI: 10.1159/000339361

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  20 in total

1.  2010 Alzheimer's disease facts and figures.

Authors: 
Journal:  Alzheimers Dement       Date:  2010-03       Impact factor: 21.566

2.  Eligibility of Alzheimer's disease clinic patients for clinical trials.

Authors:  L S Schneider; J T Olin; S A Lyness; H C Chui
Journal:  J Am Geriatr Soc       Date:  1997-08       Impact factor: 5.562

3.  Differential features of burden between spouse and adult-child caregivers of patients with Alzheimer's disease: an exploratory comparative design.

Authors:  Josep Lluís Conde-Sala; Josep Garre-Olmo; Oriol Turró-Garriga; Joan Vilalta-Franch; Secundino López-Pousa
Journal:  Int J Nurs Stud       Date:  2010-04-05       Impact factor: 5.837

4.  The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers.

Authors:  John C Morris; Sandra Weintraub; Helena C Chui; Jeffrey Cummings; Charles Decarli; Steven Ferris; Norman L Foster; Douglas Galasko; Neill Graff-Radford; Elaine R Peskind; Duane Beekly; Erin M Ramos; Walter A Kukull
Journal:  Alzheimer Dis Assoc Disord       Date:  2006 Oct-Dec       Impact factor: 2.703

5.  Quality of life of patients with Alzheimer's disease: differential perceptions between spouse and adult child caregivers.

Authors:  J L Conde-Sala; J Garre-Olmo; O Turró-Garriga; J Vilalta-Franch; S López-Pousa
Journal:  Dement Geriatr Cogn Disord       Date:  2010-02-11       Impact factor: 2.959

6.  A phase II trial of huperzine A in mild to moderate Alzheimer disease.

Authors:  M S Rafii; S Walsh; J T Little; K Behan; B Reynolds; C Ward; S Jin; R Thomas; P S Aisen
Journal:  Neurology       Date:  2011-04-19       Impact factor: 9.910

7.  Ethnoracial differences in the clinical characteristics of Alzheimer's disease at initial presentation at an urban Alzheimer's disease center.

Authors:  Melissa Gartenberg Livney; Christopher M Clark; Jason H Karlawish; Su Cartmell; Mirna Negrón; Jessica Nuñez; Sharon X Xie; Fernando Entenza-Cabrera; Irving E Vega; Steven E Arnold
Journal:  Am J Geriatr Psychiatry       Date:  2011-05       Impact factor: 4.105

8.  High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial.

Authors:  Paul S Aisen; Lon S Schneider; Mary Sano; Ramon Diaz-Arrastia; Christopher H van Dyck; Myron F Weiner; Teodoro Bottiglieri; Shelia Jin; Karen T Stokes; Ronald G Thomas; Leon J Thal
Journal:  JAMA       Date:  2008-10-15       Impact factor: 56.272

Review 9.  Potential ethnic modifiers in the assessment and treatment of Alzheimer's disease: challenges for the future.

Authors:  Warachal E Faison; Susan K Schultz; Jeroen Aerssens; Jennifer Alvidrez; Ravi Anand; Lindsay A Farrer; Lissy Jarvik; Jennifer Manly; Thomas McRae; Greer M Murphy; Jason T Olin; Darrel Regier; Mary Sano; Jacobo E Mintzer
Journal:  Int Psychogeriatr       Date:  2007-04-23       Impact factor: 3.878

10.  Factors related to perceived quality of life in patients with Alzheimer's disease: the patient's perception compared with that of caregivers.

Authors:  Josep Lluís Conde-Sala; Josep Garre-Olmo; Oriol Turró-Garriga; Secundino López-Pousa; Joan Vilalta-Franch
Journal:  Int J Geriatr Psychiatry       Date:  2009-06       Impact factor: 3.485

View more
  12 in total

1.  Study partners perform essential tasks in dementia research and can experience burdens and benefits in this role.

Authors:  Betty S Black; Holly A Taylor; Peter V Rabins; Jason Karlawish
Journal:  Dementia (London)       Date:  2016-05-13

2.  A Preliminary Study of Clinical Trial Enrollment Decisions Among People With Mild Cognitive Impairment and Their Study Partners.

Authors:  Chelsea G Cox; Mary M Ryan B A; Daniel L Gillen; Joshua D Grill
Journal:  Am J Geriatr Psychiatry       Date:  2018-11-03       Impact factor: 4.105

3.  Frequency and impact of informant replacement in Alzheimer disease research.

Authors:  Joshua D Grill; Yan Zhou; Jason Karlawish; David Elashoff
Journal:  Alzheimer Dis Assoc Disord       Date:  2015 Jul-Sep       Impact factor: 2.703

4.  Dyadic Enrollment in a Phase 3 Mild Cognitive Impairment Clinical Trial.

Authors:  Navneet R Hakhu; Daniel L Gillen; Joshua D Grill
Journal:  Alzheimer Dis Assoc Disord       Date:  2022-04-29       Impact factor: 2.357

Review 5.  Facilitating Alzheimer disease research recruitment.

Authors:  Joshua D Grill; James E Galvin
Journal:  Alzheimer Dis Assoc Disord       Date:  2014 Jan-Mar       Impact factor: 2.703

6.  Effect of study partner on the conduct of Alzheimer disease clinical trials.

Authors:  Joshua D Grill; Rema Raman; Karin Ernstrom; Paul Aisen; Jason Karlawish
Journal:  Neurology       Date:  2012-12-19       Impact factor: 9.910

7.  Researchers' perspectives on the role of study partners in dementia research.

Authors:  Betty S Black; Holly Taylor; Peter V Rabins; Jason Karlawish
Journal:  Int Psychogeriatr       Date:  2014-07-03       Impact factor: 3.878

Review 8.  Patient Engagement: The Fundació ACE Framework for Improving Recruitment and Retention in Alzheimer's Disease Research.

Authors:  Mercè Boada; Miguel A Santos-Santos; Octavio Rodríguez-Gómez; Montserrat Alegret; Pilar Cañabate; Asunción Lafuente; Carla Abdelnour; Mar Buendía; Maria José de Dios; América Morera; Ángela Sanabria; Laura Campo; Agustín Ruiz; Lluís Tárraga
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

9.  Family members' perspectives on learning cognitively unimpaired older adults' amyloid-β PET scan results.

Authors:  Emily A Largent; Maramawit Abera; Kristin Harkins; Sara J Feldman; Wendy R Uhlmann; J Scott Roberts; Jason Karlawish
Journal:  J Am Geriatr Soc       Date:  2021-07-12       Impact factor: 5.562

10.  Attitudes toward clinical trials across the Alzheimer's disease spectrum.

Authors:  Michelle M Nuño; Daniel L Gillen; Kulwant K Dosanjh; Jenny Brook; David Elashoff; John M Ringman; Joshua D Grill
Journal:  Alzheimers Res Ther       Date:  2017-10-04       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.